The regulatory role of alternative splicing in in fl ammatory bowel disease

HIGHLIGHTS

• who: April et al. from the Kyoto Pharmaceutical University, Japan have published the paper: The regulatory role of alternative splicing in in fl ammatory bowel disease, in the Journal: (JOURNAL)
• what: Alternative splicing may be related to pathogenesis, biomarker for diagnosis, and therapeutic targets for both adults and children with IBD.
• how: The results showed that many genes exhibited different kinds of alternative splicing in UC. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.